Expression, Activity and Regulation of CYP3A in Human and Rodent Brain

REFERENCES

• Aleksa K., Matsell D., Krausz D., Gelboin H., Ito S., Koren G. Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity. Pediatr. Nephrol. 2005; 20: 872–885
   PubMed Web of Science ®Google Scholar
• Anakk S., Kalsotra A., Kikuta Y., Huang W., Zhang J., Staudinger J. L., Moore D. D., Strobel H. W. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J. 2004; 4: 91–101
   PubMed Web of Science ®Google Scholar
• Anakk S., Kalsotra A., Shen Q., Vu M. T., Staudinger J. L., Davies P. J., Strobel H. W. Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. FASEB J. 2003; 17: 1736–1738
   PubMed Web of Science ®Google Scholar
• Aoyama T., Yamano S., Waxman D. J., Lapenson D. P., Meyer U. A., Fischer V., Tyndale R., Inaba T., Kalow W., Gelboin H. V., Gonzalez F. J. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J. Biol. Chem. 1989; 264: 10388–10395
   PubMed Web of Science ®Google Scholar
• Bauer B., Hartz A. M., Fricker G., Miller D. S. Pregnane X receptor up-regulation of p-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 2004; 66: 413–419
   PubMed Web of Science ®Google Scholar
• Belloc C., Baird S., Cosme J., Lecoeur S., Gautier J-C., Challine D., de Waziers I., Flinois J. P., Beaune P. H. Human cytochrome P450 expressed in Escherichia coli: production of specific antibodies. Toxicology. 1996; 106: 207–219
   PubMed Web of Science ®Google Scholar
• Bergheim I., Bode C., Parlesak A. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma. BMC Gastroenterol. 2005; 5: 34
   PubMed Web of Science ®Google Scholar
• Bhagwat S. V., Boyd M. R., Ravindranath V. Rat brain cytochrome P450: reassessment of monooxygenase activities and cytochrome P450 levels. Drug Metab. Dispos. 1995; 23: 651–654
   PubMed Web of Science ®Google Scholar
• Bhamre S., Anandatheerathaarada H. K., Shanker S. K., Ravindranath V. Microsomal cytochrome P450 in human brain regions. Biochem. Pharmacol. 1992; 44: 1223–1225
   PubMed Web of Science ®Google Scholar
• Bhamre S., Anandatheerathaarada H. K., Shanker S. K., Boyd M. R., Ravindranath V. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activites. Arch. Biochem. Biophys. 1993; 301: 251–255
   PubMed Web of Science ®Google Scholar
• Britto M. R., Wedlund P. J. Cytochrome P-450 in the brain: potential evolutionary and therapeutic relevance of localization of drug metabolizing enzymes. Drug Metab. Dispos. 1992; 20: 446–450
   PubMed Web of Science ®Google Scholar
• Burk O., Koch I., Raucy J., Hustert E., Eichelbaum M., Bröckmoller J., Zanger U. M., Wojnowski L. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J. Biol. Chem. 2004; 279: 38379–38385
   PubMed Web of Science ®Google Scholar
• Chen M., Ma L., Drusano G. L., Bertino J. S., Nafziger A. N. Sex differences in CYP3A activity using intravenous and oral midazolam. Clin. Pharmacol. Ther. 2006; 80: 531–538
   PubMed Web of Science ®Google Scholar
• Dai D., Bai R., Hodgson E., Rose R. L. Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25* (Cyp3a25), a testosterone 6β-hydroxylase. J. Biochem. Mol. Toxicol. 2001a; 15: 90–99
   PubMed Web of Science ®Google Scholar
• Dai D., Tang J., Rose R., Hodgson E., Bienstock R. J., Mohrenweiser H. W., Goldstein J. A. Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J. Pharmacol. Exp. Ther. 2001b; 299: 825–831
   PubMed Web of Science ®Google Scholar
• Dallas S., Miller D. S., Bendayan R. Multidrug resistance-associated proteins (MRPs): expression and function in the central nervous system. Pharmacol. Rev. 2006; 58: 140–161
   PubMed Web of Science ®Google Scholar
• Ding X., Staudinger J. L. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. Biochem. Pharmacol. 2005; 69: 867–873
   PubMed Web of Science ®Google Scholar
• Domanski T. L., Finta C., Halpert J. R., Zaphiropoulos P. G. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol. Pharmacol. 2001; 59: 386–392
   PubMed Web of Science ®Google Scholar
• Dragoni S., Bellik L., Frosini M., Matteucci G., Sgaragli G., Valoti M. Cytochrome P450-dependent metabolism of l-deprenyl in monkey (Cercopithecus aethiops) and C57BL/6 mouse brain microsomal preparations. J. Neurochem. 2003; 86: 1174–1180
   PubMed Web of Science ®Google Scholar
• Dvorak Z., Modriansky M., Pichard-Garcia L., Balaguer P., Vilarem M. J., Ulrichova J., Maurel P., Pascussi J. M. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol Pharmacol. 2003; 64: 160–169
   PubMed Web of Science ®Google Scholar
• Farin F. M., Omiecinski C. J. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J. Toxicol. Environ. Health 1993; 40: 317–335
   PubMed Web of Science ®Google Scholar
• Finnström N., Bjelfman C., Söderström T.G., Smith G., Egevad L., Norlen B. J., Wolf C. R., Rane A. Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR. Eur. J. Clin. Invest. 2001; 31: 880–886
   PubMed Web of Science ®Google Scholar
• Gelboin H. V., Krausz K. W., Goldfarb I., Buters J. T. M., Yang S. K., Gonzalez F. J., Korzekwa K. R., Shou M. Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Biochem. Pharmacol. 1995; 50: 1841–1850
   PubMed Web of Science ®Google Scholar
• Gervasini G., Carrillo J. A., Benitez J. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics. Clin. Pharmacokinet. 2004; 43: 693–706
   PubMed Web of Science ®Google Scholar
• Ghersi-Egea J. F., Perrin R., Leninger-Muller B., Grassiot M. C., Jeandel C., Floquet J., Cuny G., Siest G., Minn A. Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem. Pharmacol. 1993; 45: 647–658
   PubMed Web of Science ®Google Scholar
• Gnerre C., Blattler S., Kaufmann M. R., Looser R., Meyer U. A. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 2004; 14: 635–645
   PubMedGoogle Scholar
• Gonzales F. J., Yu A. Cytochrome P450 and xenobiotic receptor in humanized mice. Annu. Rev. Pharmacol. Toxicol. 2006; 46: 41–64
   PubMed Web of Science ®Google Scholar
• Goodwin B., Hodgson E., D'Costa D. J., Robertson G. R., Liddle C. Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol. 2002a; 62: 359–365
   PubMed Web of Science ®Google Scholar
• Goodwin B., Redinbo M.R., Kliewer S. A. Regulation of CYP3A gene transcription by the pregnane X receptor. Annu. Rev. Pharmacol. Toxicol. 2002b; 42: 1–23
   PubMed Web of Science ®Google Scholar
• Gorski J. C., Hall S. D., Jones D. R., Vandenbranden M., Wrighton S. A. Regioselective biotransfomation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem. Pharmacol. 1994; 47: 1643–1653
   PubMed Web of Science ®Google Scholar
• Greuet J., Pichard M., Bonfils C., Domergue J., Maurel P. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes. Biochem. Biophys. Res. Commun. 1996; 225: 689–694
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu. Rev. Pharmacol. Toxicol. 1999; 39: 1–17
   PubMed Web of Science ®Google Scholar
• Hagemeyer C. E., Rosenbrock H., Ditter M., Knoth R., Volk B. Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 2003; 117: 521–529
   PubMed Web of Science ®Google Scholar
• Hedlund E., Gustafsson J. A., Warner M. Cytochrome P450 in the brain: a review. Curr. Drug Metab. 2001; 2: 245–263
   PubMed Web of Science ®Google Scholar
• Hirota N., Ito K., Iwatsubo T., Green C. E., Tyson C. A., Shimada N., Suzuki H., Sugiyama Y. In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. Biopharm. Drug Dispos. 2001; 22: 53–71
   PubMed Web of Science ®Google Scholar
• Jayyosi Z., Cooper K. O., Thomas P. E. Brain cytochrome P450 and testosterone metabolism by rat brain subcellular fraction: presence of cytochrome P450 3A immunoreactive protein in rat brain mitochondria. Arch. Biochem. Biophys. 1992; 298: 265–270
   PubMed Web of Science ®Google Scholar
• Jin Y., Wang Y. H., Miao J., Li L., Kovacs R. J., Marunde R., Hamman M. A., Phillips S., Hilligoss J., Hall S. D. Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects. Clin. Pharmacol. Ther. 2007; 82: 579–585
   PubMed Web of Science ®Google Scholar
• Jover R., Bort R., Gomez-Lechon M. J., Castell J. V. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. 2002; 16: 1799–1801
   PubMed Web of Science ®Google Scholar
• Kharasch E. D., Walker A., Isoherranen N., Hoffer C., Sheffels P., Thummel K., Whittington D., Ensign D. Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam. Clin. Pharmacol. Ther. 2007; 82: 410–426
   PubMed Web of Science ®Google Scholar
• Kirches E., Scherlach C., von Bossanyi P., Schneider T., Szibor R., Kutz E., Warich-Kirches M., Dietzmann K. MGMT- and P450 3A-inhibitors do not sensitize glioblastoma cell cultures against nitrosoureas. Clin. Neuropathol. 1999; 18: 1–8
   PubMed Web of Science ®Google Scholar
• Kliewer S. A., Moore J. T., Wade L., Staudinger J. L., Watson M. A., Jones S. A., McKee D. D., Oliver B. B., Willson T. M., Zetterström R. H., Perlmann T., Lehmann J. M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998; 92: 73–82
   PubMed Web of Science ®Google Scholar
• Koch I., Weil R., Wolbold R., Brockmöller J., Hustert E., Burk O., Nuessler A., Neuhaus P., Eichelbaum M., Zanger U., Wojnowski L. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab. Dispos. 2002; 30: 1108–1114
   PubMed Web of Science ®Google Scholar
• Krishna D. R., Shekar M. S. Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences. Methods Find. Exp. Clin. Pharmacol. 2005; 27: 559–567
   PubMed Web of Science ®Google Scholar
• Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schuetz J., Watkins P. B., Daly A., Wrighton S. A., Hall S. D., Maurel P., Relling M., Brimer C., Yasuda K., Venkataramanan R., Strom S., Thummel K., Boguski M. S., Schuetz E. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 2001; 27: 383–391
   PubMed Web of Science ®Google Scholar
• Lamba J. K., Lin Y. S., Schuetz E. G., Thummel K. E. Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv. Rev. 2002a; 54: 1271–1294
   PubMed Web of Science ®Google Scholar
• Lamba J. K., Lin Y. S., Thummel K., Daly A., Watkins P. B., Strom S., Zhang J., Schuetz E. G. Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics 2002b; 12: 121–132
   PubMedGoogle Scholar
• Lamba V., Yasuda K., Lamba J. K., Assem M., Davila J., Strom S., Schuetz E. G. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol. Appl. Pharmacol. 2004a; 199: 251–265
   PubMed Web of Science ®Google Scholar
• Lamba J. K., Lamba V., Yasuda K., Lin Y. S., Assem M., Thompson E., Strom S., Schuetz E. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther. 2004b; 311: 811–821
   PubMed Web of Science ®Google Scholar
• LeCluyse E. L. Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics. Chem. Biol. Interact. 2001; 134: 283–289
   PubMed Web of Science ®Google Scholar
• Lee G., Bendayan R. Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders. Pharm. Res. 2004; 21: 1313–1330
   PubMed Web of Science ®Google Scholar
• Li Y., Yokoi T., Kitamura R., Sasaki M., Gunji M., Katsuki M., Kamataki T. Establishment of transgenic mice carrying human fetus-specific CYP3A7. Arch. Biochem. Biophys. 1996; 329: 235–240
   PubMed Web of Science ®Google Scholar
• Marini S., Nannelli A., Sodini D., Dragoni S., Valoti M., Longo V., Gervasi P. G. Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sci. 2007; 80: 910–917
   PubMed Web of Science ®Google Scholar
• Martignoni M., Groothuis G. M., de Kanter R. Species differences between mouse, rat, dog, monkey and human cytochrome P450-mediated drug metabolism. Expert Opin. Drug Metab. Toxicol. 2006; 2: 875–894
   PubMed Web of Science ®Google Scholar
• Matheny C. J., Ali R. Y., Yang X. D., Pollack G. M. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues. Drug Metab. Dispos. 2004; 32: 1008–1014
   PubMed Web of Science ®Google Scholar
• Matsubara T., Kim H. J., Miyata M., Shimada M., Nagata K., Yamazoe Y. Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat. J. Pharmacol. Exp. Ther. 2004; 309: 1282–1290
   PubMed Web of Science ®Google Scholar
• McCune J. S., Risler L. J., Phillips B. R., Thummel K. E., Blough D., Shen D. D. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab. Dispos. 2005; 33: 1074–1081
   PubMed Web of Science ®Google Scholar
• McFadyen M. C., Melvin W. T., Murray G. I. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem. Pharmacol. 1998; 55: 825–830
   PubMed Web of Science ®Google Scholar
• Mei Q., Richards K., Strong-Basalyga K., Fauty S. E., Taylor A., Yamazaki M., Prueksaritanont T., Lin J. H., Hochman J. Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat p-glycoproteins mdr1a/1b and cytochrome P450 3A1/2. J. Pharm. Sci. 2004; 93: 2488–2496
   PubMed Web of Science ®Google Scholar
• Miksys S. L., Tyndale R. F. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab. Revs. 2004; 36: 313–333
   PubMed Web of Science ®Google Scholar
• Cytochrome P450, Structure, Mechanism and Biochemistry3^rd, P. R. Ortiz de Montellano. Kluwer/Plenum Press, New York 2005
   Google Scholar
• Ozdemir V., Kalow W., Tang B. K., Paterson A. D., Walker S. E., Endrenyi L., Kashuba A. D. Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics 2000; 10: 373–388
   PubMedGoogle Scholar
• Pai H. V., Upadhya S. C., Chinta S. J., Hegde S. N., Ravindranath V. Differential metabolism of alprazolam by liver and brain cytochrome P4503A to pharmacologically active metabolite. Pharmacogenomics J. 2002; 2: 243–258
   PubMedGoogle Scholar
• Paine M. F., Hart H. L., Ludington S. S., Haining R. L., Rettie A. E., Zeldin D. C. The human intestinal cytochrome P450 “pie”. Drug Metab. Dispos 2006; 34: 880–886
   PubMed Web of Science ®Google Scholar
• Perloff M. D., von Moltke L. L., Court M. H., Kotegawa T., Shader R. I., Greenblatt D. J. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. J. Pharmacol. Exp. Ther. 2000; 292: 618–628
   PubMed Web of Science ®Google Scholar
• Quattrochi L. C., Guzelian P. S. CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab. Dispos. 2001; 29: 615–622
   PubMed Web of Science ®Google Scholar
• Raunio H., Hakkola J., Pelkonnen O. Regulation of CYP3A genes in the human respiratory tract. Chem. Biol. Interact 2005; 151: 53–62
   PubMed Web of Science ®Google Scholar
• Ravindranath V. Metabolism by xenobiotics in the central nervous system: implications and challenges. Biochem. Pharmacol. 1998; 56: 547–551
   PubMed Web of Science ®Google Scholar
• Ravindranath V., Anandatheerthavarada H. K. Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method. Anal. Biochem. 1990; 187: 310–313
   PubMed Web of Science ®Google Scholar
• Ravindranath V., Kommaddi R. P., Pai H. V. Unique cytochromes P450 in human brain: implications in disease pathogenesis. J. Neural. Transm. 2006; 70: 167–171
   Google Scholar
• Robertson G. R., Field J., Goodwin B., Bierach S., Tran M., Lehnert A., Liddle C. Transgenic mouse models of human CYP3A4 gene regulation. Mol. Pharmacol. 2003; 64: 42–50
   PubMed Web of Science ®Google Scholar
• Ronaldson P. T., Lee G., Dallas S., Bendayan R. Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines. Pharm. Res. 2004; 21: 811–818
   PubMed Web of Science ®Google Scholar
• Ronaldson P. T., Bendayan R. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol. Pharmacol. 2006; 70: 1087–1098
   PubMed Web of Science ®Google Scholar
• Rosenbrock H., Hagmeyer C. E., Ditter M., Knoth R., Volk B. Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain. Neurotox. Res. 2001; 4: 339–349
   Web of Science ®Google Scholar
• Rosenbrock H., Hagemeyer C. E., Singec I., Knoth R., Volk B. Testosterone metabolism in rat brain is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms. J. Neuroendocrinol. 1999; 11: 597–604
   PubMed Web of Science ®Google Scholar
• Schilter B., Omiecinski C. J. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol. Pharmacol. 1993; 44: 990–996
   PubMed Web of Science ®Google Scholar
• Schilter B., Andersen M. R., Acharya C., Omiecinski C. J. Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers. J. Pharmacol. Exp. Ther. 2000; 294: 916–922
   PubMed Web of Science ®Google Scholar
• Schmidt R., Baumann F., Hanschmann H., Geissler F., Preiss R. Gender difference in ifosfamide metabolism by human liver microsomes. Eur. J. Drug Metab. Pharmacokinet. 2001; 26: 193–200
   PubMed Web of Science ®Google Scholar
• Schuetz J. D., Beach D. L., Guzelian P. S. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult liver. Pharmacogenetics 1994; 4: 11–20
   PubMedGoogle Scholar
• Sequeira D. J., Strobel H. W. In vitro metabolism of imipramine by brain microsomes: effects of inhibitors and exogenous cytochrome P450 reductase. Brain Res. 1996; 738: 24–31
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 1994; 270: 414–423
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Wakamiya N., Ueng Y. F., Guengerich F. P., Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab. Dispos. 1996; 24: 515–522
   PubMed Web of Science ®Google Scholar
• Sim S. C., Edwards R. J., Boobis A. R., Ingelman-Sundberg M. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele Pharmacogenet. Genomics 2005; 15: 625–631
   PubMed Web of Science ®Google Scholar
• Souidi M., Guegan Y., Linard C., Dudoignon N., Grison S., Baudelin C., Marquette C., Gourmelon P., Aigueperse J., Dublineau I. In vivo effects of chronic contamination with depleted uranium on CYP3A and associated nuclear receptors PXR and CAR in the rat. Toxicology 2005; 214: 113–122
   PubMed Web of Science ®Google Scholar
• Soars M.G., Grime K., Riley R. J. Comparative analysis of substrate and inhibitor interactions with CYP3A4 and CYP3A5. Xenobiotica 2006; 36: 287–299
   PubMed Web of Science ®Google Scholar
• Stanley L. A., Horsburgh B. C., Ross J., Scheer N., Wolf C. R. PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab. Rev. 2006; 38: 515–597
   PubMed Web of Science ®Google Scholar
• Strobel H. W., Thompson C. M., Antonovic L. Cytochrome P450 in brain: function and significance. Curr. Drug Metab. 2001; 2: 199–214
   PubMed Web of Science ®Google Scholar
• Sugita O., Miyairi S., Sassa S., Kappas A. Partial purification of cytochrome P450 from rat brain and demonstration of estradiol hydroxylation. Biochem. Biophys. Res Commun. 1987; 147: 1245–1250
   PubMed Web of Science ®Google Scholar
• Thummel K. E., Wilkinson G. R. In vitro and in vivo drug interactions involving human CYP3A. Annu. Rev. Pharmacol. Toxicol. 1998; 38: 389–430
   PubMed Web of Science ®Google Scholar
• Thummel K. E., Brimer C., Yasuda K. Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxyvitamin D3. Mol. Pharmacol. 2001; 60: 1399–1406
   PubMed Web of Science ®Google Scholar
• Timsit Y. E., Negishi M. CAR and PXR: the xenobiotic-sensing receptors. Steroids 2007; 72: 231–246
   PubMed Web of Science ®Google Scholar
• Upadhya S. C., Chinta S. J., Pai H. V., Boyd M. R., Ravindranath V. Toxicological consequences of differential regulation of cytochrome P450 isoforms in rat brain regions by phenobarbital. Arch. Biochem. Biophys. 2002; 399: 56–65
   PubMed Web of Science ®Google Scholar
• Vences-Mejía A., Labra-Ruíz N., Hernández-Martínez N., Dorado-González V., Gómez-Garduño J., Pérez-López I., Nosti-Palacios R., Camacho Carranza R., Espinosa-Aguirre J.J. The effect of aspartame on rat brain xenobiotic-metabolizing enzymes. Hum. Exp. Toxicol. 2006; 25: 453–459
   PubMed Web of Science ®Google Scholar
• Voice M. W., Zhang Y., Wolf C. R., Burchell B., Friedberg T. Effects of human cytochrome b5 on CYP3A4 activity and stability in vivo. Arch. Biochem. Biophys. 1999; 366: 116–124
   PubMed Web of Science ®Google Scholar
• Voirol P., Jonzier-Perey M., Porchet F., Reymond M. J., Janzer R. C., Bouras C., Strobel H. W., Kosel M., Eap C. B., Baumann P. Cytochrome P-450 activities in human and rat brain microsomes. Brain Res. 2000; 855: 235–243
   PubMed Web of Science ®Google Scholar
• Wang H., Kawashima H., Strobel H. W. cDNA cloning of a novel CYP3A from rat brain. Biochem. Biophys. Res. Commun. 1996; 221: 157–162
   PubMed Web of Science ®Google Scholar
• Wang H. M., Napoli K. L., Strobel H. W. Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol. Cell Biochem. 2000; 213: 127–135
   PubMed Web of Science ®Google Scholar
• Wang H. M., Strobel H. W. Regulation of CYP3A9 gene expression and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch. Biochem. Biophys. 1997; 344: 365–372
   PubMed Web of Science ®Google Scholar
• Warner M., Kohler C., Hansson T., Gustafsson J. A. Regional distribution of cytochrome P-450 in the rat brain: Spectral quantitation and contribution of P-450b, e and P-450c, d. J. Neurochem. 1988; 50: 1057–1065
   PubMed Web of Science ®Google Scholar
• Westlind A., Malmebo S., Johansson I., Otter C., Andersson T. B., Ingelman-Sundberg M., Oscarson M. Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43. Biochem. Biophys. Res. Commun. 2001; 281: 1349–1355
   PubMed Web of Science ®Google Scholar
• Westlind-Johnsson A., Malmebo S., Johansson A., Otter C., Andersson T. B., Johansson I., Edwards R. J., Boobis A. R., Ingelman-Sundberg M. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab. Dispos. 2003; 31: 755–761
   PubMed Web of Science ®Google Scholar
• Westlind-Johnsson A., Hermann R., Huennemeyer A., Hauns B., Lahu G., Nassr N., Zech K., Ingelman-Sundberg M., von Richter O. Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity. Clin. Pharmacol. Ther. 2006; 79: 339–349
   PubMed Web of Science ®Google Scholar
• Wilkinson G. R. Drug metabolism and variability among patients in drug response. N. Engl. J. Med. 2005; 352: 2211–2221
   PubMed Web of Science ®Google Scholar
• Wolbold R., Klein K., Burk O., Nüssler A. K., Neuhaus P., Eichelbaum M., Schwab M., Zanger U. M. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 2003; 38: 978–988
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Brian W. R., Sari M. A., Iwasaki M., Guengerich F. P., Raucy J. L., Molowa D. T., Van den Branden M. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 1990; 38: 207–213
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 1992; 22: 1–21
   PubMed Web of Science ®Google Scholar
• Xie W., Uppal H., Saini S. P., Mu Y., Little J. M., Radominska-Pandya A., Zemaitis M. A. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discov. Today 2004; 15: 442–449
   Web of Science ®Google Scholar
• Yadav S., Dhawan A., Seth P. K., Singh R. L., Parmar D. Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain. Mol. Cell Biochem. 2006; 287: 91–99
   PubMed Web of Science ®Google Scholar
• Zuber R., Anzenbacherova E., Anzenbacher P. Cytochromes P450 and experimental models of drug metabolism. J. Cell. Mol. Med. 2002; 6: 189–198
   PubMed Web of Science ®Google Scholar